AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.

The entities involved

• AbbVie →

  pharmaceutical company

  • The FDA approved a Skyrizi regimen for Crohn's disease, based on an AFFIRM trial led by UNC.01:48
  • AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Fri 21:49
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • Amundi increased its stake in Johnson & Johnson, while Bank of America, Morgan Stanley, and TD Cowen issued rating and price target updates on the company.13:23
  • Johnson & Johnson and Mastercard are currently top holdings within the JEPI investment fund.Fri 04:13
• Bristol-Myers Squibb →

  American pharmaceutical company

  • University of Hyderabad is hosting a drug discovery program featuring scientists from Pfizer and Bristol-Myers Squibb in Hyderabad.Fri 16:43
  • Pfizer, J&J, BMS, Sanofi, and AbbVie are leading innovation in personalized therapies and are key players in the multiple myeloma treatment market.Thu 14:49
• Amgen →

  American multinational biopharmaceutical company

  • Zai Lab presented data at a meeting in Barcelona, involving researcher Pedro Rocha and Amgen.21:36
  • Major pharmaceutical companies, including Pfizer, Amgen, Eli Lilly, and Novo Nordisk, are leading the market in next-generation GLP-1 drugs for weight loss and diabetes.Thu 13:45

Related events

• AbbVie, Boehringer Ingelheim, and Pfizer were present at a clinical conference in Las Vegas.Oct 10
• Bristol-Myers Squibb and Novo Nordisk are noted as competitors in the healthcare sector.Oct 11
• A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.Jun 24